Neuraltus Pharmaceuticals' Series A - III Round

Neuraltus Pharmaceuticals raised a round of funding on May 31, 2012.

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physician…

Articles about Neuraltus Pharmaceuticals' Series A - III Round: